Hims & Hers Health (HIMS) EBT Growth (3y) (2022 - 2026)
Hims & Hers Health (HIMS) EBT Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 53.36% |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | 2.84% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -64.71% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 2.93% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | -40.38% |
| 8 | Neurocrine Biosciences | 17.87 Bn | 16.55 Bn | 800.70 Mn | 63.73% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -6.95% |
| 10 | Hims & Hers Health | 6.73 Bn | 5.98 Bn | 396.79 Mn | -118.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118.90% |
| Dec 31, 2025 | 54.17% |
| Sep 30, 2025 | 38.35% |
| Jun 30, 2025 | 54.26% |
| Mar 31, 2025 | 79.09% |
| Dec 31, 2024 | 39.48% |
| Sep 30, 2024 | 47.89% |
| Jun 30, 2024 | 51.42% |
| Mar 31, 2024 | 30.88% |
| Dec 31, 2023 | 34.29% |
| Sep 30, 2023 | -5.80% |
| Jun 30, 2023 | -96.57% |
| Mar 31, 2023 | -17.30% |
| Dec 31, 2022 | -126.45% |
| Sep 30, 2022 | -260.77% |
| Jun 30, 2022 | -958.01% |